Regulation of Cellular Retinoic Acid Binding Protein (CRABP II) during Human Monocyte Differentiationin Vitro
Authors:
- Marina KreutzMKMarina Kreutz
- Jana FritscheJFJana Fritsche
- Reinhard AndreesenRAReinhard Andreesen
- Stefan W. KrauseSKStefan W. Krause
- 1 July 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 248 (3) , 830-834
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Biochemical Pathways of Retinoid Transport, Metabolism, and Signal TransductionClinical Immunology and Immunopathology, 1996
- Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptorNature, 1995
- Epidermal Differentiation Enhances CRABP II Expression in Human SkinJournal of Investigative Dermatology, 1994
- Topical glucocorticosteroids modulate the expression of CRABP I and II in human skin differentlyExperimental Dermatology, 1994
- A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage.Proceedings of the National Academy of Sciences, 1993
- All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifsCell, 1992
- Multiplicity generates diversity in the retinoic acid signalling pathwaysTrends in Biochemical Sciences, 1992
- Retinoic Acid Receptors and Binding Proteins in Human SkinJournal of Investigative Dermatology, 1992
- Retinoic acid is a negative regulator of AP-1-responsive genes.Proceedings of the National Academy of Sciences, 1991
- Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells.Journal of Cell Biology, 1991